The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

U.S. health officials have expanded approval of a drug that boosts libido in women who report stress due to a low sex drive ...

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some ...

This is read by an automated voice. Please report any issues or inconsistencies here. The FDA is removing a 22-year-old warning label from hormone-based menopause drugs, saying newer evidence shows ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...

For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn't until ...

New national data reveal a sharp rise in GLP-1 prescriptions for young women, but low contraception use leaves many at risk of unintended pregnancy and uncertain outcomes for their babies. Study: ...